Hospital Plaza Foot & Ankle Sc

CLIA Laboratory Citation Details

3
Total Citations
16
Total Deficiencyies
13
Unique D-Tags
CMS Certification Number 14D0877152
Address 1228 Ogden Ave, Downers Grove, IL, 60515
City Downers Grove
State IL
Zip Code60515
Phone(630) 810-9966

Citation History (3 surveys)

Survey - December 5, 2024

Survey Type: Standard

Survey Event ID: DOVP13

Deficiency Tags: D0000 D5411 D5421

Summary:

Summary Statement of Deficiencies D0000 An unannounced revisit survey was performed on 12-05-2024 as a follow-up to the 10- 01-2024, recertification survey. The Illinois Department of Public health has evaluated this facility and determined it remains out of compliance with the following Conditions CFR(s): 493.1203 Condition: Mycology CFR(s): 493.1403 Condition: Laboratories performing moderately complexity testing; laboratory director D5411 TEST SYSTEMS, EQUIPMENT, INSTRUMENTS, REAGENT CFR(s): 493.1252(a) Test systems must be selected by the laboratory. The testing must be performed following the manufacturer's instructions and in a manner that provides test results within the laboratory's stated performance specifications for each test system as determined under 493.1253. This STANDARD is not met as evidenced by: Based on review of manufacturer's instructions, and interview with laboratory director (LD); the laboratory failed to follow manufacturer's instructions for the storage of Kwik-STIK quality control reagent for mycology testing for one of one month in 2024. 1. Interview with LD, on 12-05-2024, at 10:30 am, revealed the laboratory had purchased Kwik-STIK quality control reagent used for mycology testing. 2. Review of the manufacturer's instructions for Kwik-STIK states under "storage and expiration" to "Store LYFO DISK and KWIK-STIK microorganisms at 2o C to 8o C in original seal vial or seal foiled pouch containing a desiccant." 3. Interview with LD, on 12-05-2024, at 11:20 am, revealed the Kwik-Stick reagents had been stored in the cabinet prior to use and surveyors confirmed that the laboratory failed to store Kwik- STICK quality control reagent in the required storage conditions in December of 2024. D5421 ESTABLISHMENT AND VERIFICATION OF PERFORMANCE CFR(s): 493.1253(b)(1) Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 2 -- Each laboratory that introduces an unmodified, FDA-cleared or approved test system must do the following before reporting patient test results: (1)(i) Demonstrate that it can obtain performance specifications comparable to those established by the manufacturer for the following performance characteristics: (1)(i)(A) Accuracy. (1)(i) (B) Precision. (1)(i)(C) Reportable range of test results for the test system. (1)(ii) Verify that the manufacturer's reference intervals (normal values) are appropriate for the laboratory's patient population. This STANDARD is not met as evidenced by: Based on review of laboratory records, direct observation, and interview with laboratory director (LD), the laboratory failed to demonstrate they can obtain performance specification comparable to those established by the manufacturer for Dermatophyte Test Medium (DTM) testing. Findings Include: 1. Direct observation of laboratory testing supplies on 12-05-2024 at 10:00 am identified the Hardy Diagnostics Dermatophyte Test Medium (DTM) (Catalog No. L27) 10ml vial used for mycology testing. 2. Review of laboratory records revealed the laboratory was using BD BBL Dermatophyte Test medium during previous survey on 10-01-2024. 3. Review of laboratory records titled "Quality Control Process (Each DTM Lot)" revealed the laboratory was using ACU-DTM for DTM testing prior to May of 2023. 4. Interview with LD, on 12-05-2024, at 10:00 am, confirmed that the laboratory failed to demonstrate they can obtain performance specifications comparable to those established by the manufacture for DTM for the change in test system in May of 2023 and the change in test system in November of 2024. -- 2 of 2 --

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access

Survey - October 1, 2024

Survey Type: Standard

Survey Event ID: DOVP11

Deficiency Tags: D5006 D5403 D5407 D5413 D5469 D5805 D6000 D6021 D6031

Summary:

Summary Statement of Deficiencies D5006 MYCOLOGY CFR(s): 493.1203 If the laboratory provides services in the subspecialty of Mycology, the laboratory must meet the requirements specified in 493.1230 through 493.1256, 493.1263, and 493.1281 through 493.1299. This CONDITION is not met as evidenced by: Based on review of the laboratory's policy and procedure manual, laboratory records, patient test logs, quality control records, and interview with the laboratory director (LD); the laboratory failed to outline the required components of a test procedure for dermatophyte test medium (DTM) (See D5403); the laboratory failed to ensure the procedures for dermatophyte testing in the sub-specialty of mycology were approved, signed, and dated by the current LD before use. (See D5407); the laboratory failed to monitor and document manufacturer's required conditions for proper storage of DTM (See D5413); the laboratory failed to verify the criteria for acceptability of control materials for eight of eight lots of dermatophyte test medium (DTM) (See D5469); and the laboratory failed to include all the required components of a laboratory test report for patient test reports for testing using DTM (See D5805). D5403 PROCEDURE MANUAL CFR(s): 493.1251(b) The procedure manual must include the following when applicable to the test procedure: (1) Requirements for patient preparation; specimen collection, labeling, storage, preservation, transportation, processing, and referral; and criteria for specimen acceptability and rejection as described in 493.1242. (2) Microscopic examination, including the detection of inadequately prepared slides. (3) Step-by-step performance of the procedure, including test calculations and interpretation of results. (4) Preparation of slides, solutions, calibrators, controls, reagents, stains, and other Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 6 -- materials used in testing. (5) Calibration and calibration verification procedures. (6) The reportable range for test results for the test system as established or verified in 493.1253. (7) Control procedures. (8)

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access

Survey - October 4, 2018

Survey Type: Standard

Survey Event ID: WTB011

Deficiency Tags: D5006 D5411 D5477 D5805

Summary:

Summary Statement of Deficiencies D5006 MYCOLOGY CFR(s): 493.1203 If the laboratory provides services in the subspecialty of Mycology, the laboratory must meet the requirements specified in 493.1230 through 493.1256, 493.1263, and 493.1281 through 493.1299. This CONDITION is not met as evidenced by: Based on review of laboratory records and interview with the laboratory director (LD); the laboratory failed to meet the requirements specified in 493.1230 through 493.1256, 493.1263, and 493.1281 through 493.1299. Findings Include: 1. The laboratory failed to ensure the manufacturer's instructions were followed. Dermatophyte test medium (DTM) cultures were reported after incubations longer than 14 days. See D5411. 2. The laboratory failed to check each batch of dermatophyte test media (DTM) for sterility, growth, inhibition, and biochemical response with initial use. See D5477. D5411 TEST SYSTEMS, EQUIPMENT, INSTRUMENTS, REAGENT CFR(s): 493.1252(a) Test systems must be selected by the laboratory. The testing must be performed following the manufacturer's instructions and in a manner that provides test results within the laboratory's stated performance specifications for each test system as determined under 493.1253. This STANDARD is not met as evidenced by: Based on review of laboratory records and interview with the laboratory director (LD); the laboratory failed to follow manufacturer's instructions for Dermatophyte Test Medium (DTM) cultures by reporting results of cultures which were incubated Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 3 -- longer than 14 days. Findings Include: 1. Review of manufacturer's instructions for "Dermatophyte Test Medium" (DTM) identified the following under the subsection "X. Procedure", "incubate the inoculated plate at 22-25C for up to 14 days." Additionally, under the section, "XII. Laboratory Results" the instructions state, "disregard any color changes in the medium after 14 days of incubation." 2. Review of patient test reports for 5 of 5 DTM culture results found the cultures were incubated and resulted beyond the 14 day time point as well as reporting the color change of the media. Patient Identifier Culture Inoculated Culture Read P1 09-10-2018 10-02-2018 P2 06-17-2018 07-19-2018 P3 05-08-2018 05-23-2018 P4 11-14-2017 01-02-2018 P5 06-26-2017 07-31-2017 3. Additionally, review of the laboratory's "specimen record sheets", which provide the culture inoculation date and the date when the culture is read, found for June of 2018 31 of 47 cultures were read beyond the 14 day time point. 4. On survey date 10-4-2018, at 11:00 am, the LD confirmed that DTM cultures identified were incubated beyond the manufacturer's instructions of 14 days. D5477 CONTROL PROCEDURES CFR(s): 493.1256(e)(4)(g) (e) For reagent, media, and supply checks, the laboratory must do the following: (e) (4) Before, or concurrent with the initial use-- (e)(4)(i) Check each batch of media for sterility if sterility is required for testing; (e)(4)(ii) Check each batch of media for its ability to support growth and, as appropriate, select or inhibit specific organisms or produce a biochemical response; and (e)(4)(iii) Document the physical characteristics of the media when compromised and report any deterioration in the media to the manufacturer. (g) The laboratory must document all control procedures performed. This STANDARD is not met as evidenced by: Based on review of laboratory records and interview with the laboratory director (LD); the laboratory failed to check each batch of dermatophyte test medium (DTM) for sterility, ability to support growth, inhibit specific organisms, and the ability to selectively induce a biochemical response. Findings include: 1. Review of the laboratory procedure, "Handling Procedures for D.T.M. Vials", under the section, "User Quality Control", states the following: "Incubate 2 samples at 71.6-88 degrees F for 14 days and examine for sterility Based on CLIA test lot samples of media with stock cultures know for positive and negative results. Full color changes in 3-6 days. Candida Abbicans: Growth, not color change Trichoplyton Mentagrophutes: Growth, color change to red E. Coli: (- G/ -CC)" 2. Review of "D.T.M. Purchase Record Sheet" logs for 2017 through the date of survey 2018 (10-4-2018) identified 7 lots of media received by the laboratory for use in patient testing. DTM Lot #s 1632207 1623005 1704514 1707409 1810013 1812906 1812916 3. "D.T.M. Purchase Record Sheet" logs for 2017 through the date of survey 2018 (10-04-2018) documented quality control testing for 7 of 7 lots for E. coli and T. rubrum. 4. "D.T.M. Purchase Record Sheet" logs failed to document quality control testing for 7 of 7 DTM lots for sterility, Candida Albicans, and Trichophyton Mentagrophytes, as outlined in the laboratory procedure, "Handling Procedures for D.T.M. Vials". 5. Review of "Specimen Record sheet" logs for 2018 documented 248 DTM cultures have been performed when quality controls for DTM culture media failed to follow the laboratory's procedure. 6. On survey date 10-04-2018, at 11:00 am, the survey findings were confirmed by the LD. D5805 TEST REPORT CFR(s): 493.1291(c) -- 2 of 3 -- The test report must indicate the following: (c)(1) For positive patient identification, either the patient's name and identification number, or a unique patient identifier and identification number. (c)(2) The name and address of the laboratory location where the test was performed. (c)(3) The test report date. (c)(4) The test performed. (c)(5) Specimen source, when appropriate. (c)(6) The test result and, if applicable, the units of measurement or interpretation, or both. (c)(7) Any information regarding the condition and disposition of specimens that do not meet the laboratory's criteria for acceptability. This STANDARD is not met as evidenced by: Based on review of laboratory records and interview with the laboratory director (LD); the laboratory failed to include the test report date for 3 of 5 dermatophyte test medium (DTM) patient test reports reviewed. Findings Include: 1. Review of 3 of 5 patient test reports for dermatophyte test medium (DTM) cultures failed to indicate the test report date. Patient Test Report Identification P2 P4 P5 2. During survey date 10-04-2018, at 11:00 am, the above findings were confirmed by the LD. -- 3 of 3 --

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access